2-(benzisothiazol-3-yloxy)acetic acid | 82152-01-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 2-(benzisothiazol-3-yloxy)acetic acid
• 英文别名: 2-(1,2-Benzothiazol-3-yloxy)acetic acid
• CAS: 82152-01-0
• 化学式: C₉H₇NO₃S
• 分子量: 209.225
• InChiKey: JVWBNFOYUNULSS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  87.7
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  1,2-苯并异噻唑-3(2H)-酮钠盐 在 sodium hydroxide 作用下， 以 水 、 二甲基亚砜 为溶剂， 反应 5.0h， 生成 2-(benzisothiazol-3-yloxy)acetic acid
  参考文献：
  名称：

  Maggiali; Mingiardi; Lugari Mangia, Farmaco, Edizione Scientifica, 1982, vol. 37, # 5, p. 319 - 327

  摘要：

  DOI：

文献信息

• Synthesis and anti-bacterial activity of a library of 1,2-benzisothiazol-3(2H)-one (BIT) derivatives amenable of crosslinking to polysaccharides
  作者：Fiorenza Viani、Bianca Rossi、Walter Panzeri、Luca Merlini、Alessandra M. Martorana、Alessandra Polissi、Yves M. Galante

  DOI：10.1016/j.tet.2017.02.025

  日期：2017.3

  1,2-Benzisothiazol-3(2H)-one (BIT) is one of the most common chemical biocides in industrial products, with a heterocyclic structure and a wide range of antimicrobial activity. A library of BIT derivatives was synthesized and characterized, from which 18 compounds were selected, tested for anti-bacterial activity relative to the parent molecule and amenable of coupling to plant polysaccharides in general

  1,2-苯并异噻唑-3（2H）-一（BIT）是工业产品中最常见的化学杀菌剂之一，具有杂环结构和广泛的抗菌活性。合成并表征了BIT衍生物的文库，从中选择了18种化合物，测试了相对于母体分子的抗菌活性，并适于与一般植物多糖，尤其是半乳甘露聚糖（GM）偶联，广泛用作流变学修饰剂，但“生物稳定性”有限。靶向BIT核心上的四个位点：杂环上的氮和氧原子，芳环上的C5和C6位置，引入了官能团。这项工作的最终目的是确定是否通过将杀生物剂与GM聚合物共价连接，可以提高其“生物稳定性”。
• DERIVATIVES OF BENZO[D]ISOTHIAZOLES AS HISTONES DEACETYLASE INHIBITORS
  申请人：Gomez Vidal Jose Antonio

  公开号：US20090312377A1

  公开（公告）日：2009-12-17

  The invention relates to derivatives of benzo[d]isothiazoles as histone deacetylase inhibitors, selected from among compounds of general formula (Ia) and (Ib) or one of the salts thereof, particularly one of the pharmaceutically acceptable salts thereof, or one of the corresponding solvates thereof. These compounds are histone deacetylase enzyme inhibitors and are suitable as pharmacologically active agents in a medicament for the treatment and/or prophylaxis of disorders or diseases associated to histone deacetylases. The invention also describes a process for obtaining the mentioned compounds and the pharmaceutical compositions containing them